Total Payments
$33,411
2019 Payments
$164.00
Companies
5
Transactions
50
Medicare Patients
122
Medicare Billing
$12,963
Payment Breakdown by Category
Other$25,410 (76.1%)
Travel$6,949 (20.8%)
Food & Beverage$828.41 (2.5%)
Education$223.95 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,410 | 11 | 76.1% |
| Travel and Lodging | $6,949 | 17 | 20.8% |
| Food and Beverage | $828.41 | 19 | 2.5% |
| Education | $223.95 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $33,150 | 45 | $0 (2017) |
| Janssen Products, LP | $158.95 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $65.00 | 1 | $0 (2019) |
| Theravance Biopharma Inc. | $22.21 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $14.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $164.00 | 2 | Janssen Products, LP ($99.00) |
| 2017 | $33,247 | 48 | Merck Sharp & Dohme Corporation ($33,150) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2019 | Janssen Products, LP | Symtuza (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/04/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.00 | General |
| 11/30/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $4.59 | General |
| 07/27/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $4.80 | General |
| 07/11/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/11/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/29/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $105.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | Cash or cash equivalent | $75.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $237.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $606.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $571.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $564.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $137.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $80.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/13/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $8.18 | General |
| 05/30/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $902.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Travel and Lodging | In-kind items and services | $681.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 43 | $10,539 | $3,650 |
| 2022 | 3 | 47 | 80 | $18,897 | $5,344 |
| 2021 | 2 | 30 | 43 | $7,804 | $2,284 |
| 2020 | 1 | 14 | 29 | $5,336 | $1,686 |
Total Patients
122
Total Services
195
Medicare Billing
$12,963
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 26 | $3,926 | $1,946 | 49.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $6,613 | $1,704 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 55 | $10,120 | $3,038 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $5,057 | $1,365 | 27.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,720 | $941.28 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 31 | $5,704 | $1,748 | 30.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 12 | $2,100 | $536.24 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 29 | $5,336 | $1,686 | 31.6% |
About Dr. Amy Ray, MD
Dr. Amy Ray, MD is a Infectious Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720090590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Ray, MD has received a total of $33,411 in payments from pharmaceutical and medical device companies, with $164.00 received in 2019. These payments were reported across 50 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,410).
As a Medicare-enrolled provider, Ray has provided services to 122 Medicare beneficiaries, totaling 195 services with total Medicare billing of $12,963. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Cleveland, OH
- Active Since 08/12/2006
- Last Updated 12/27/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1720090590
Products in Payments
- ZERBAXA (Drug) $16,461
- DIFICID (Drug) $13,642
- SIVEXTRO (Drug) $3,004
- Symtuza (Drug) $99.00
- PREZCOBIX (Drug) $74.84
- VIBATIV (Drug) $22.21
- NOXAFIL (Drug) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Cleveland
Steven Gordon, Md, MD
Infectious Disease — Payments: $161,172
Infectious Disease $161,172
Melissa Jenkins, Md, MD
Infectious Disease — Payments: $159,244
Infectious Disease $159,244
Grace Mccomsey, Md, MD
Infectious Disease — Payments: $125,254
Infectious Disease $125,254
Alan Jay Taege, Md, MD
Infectious Disease — Payments: $107,534
Infectious Disease $107,534
Dr. Robin Jump, Md, Phd, MD, PHD
Infectious Disease — Payments: $56,857
Infectious Disease $56,857
Dr. Robert Bonomo, Md, MD
Infectious Disease — Payments: $52,004
Infectious Disease $52,004